Fig. 1From: The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancerOverall survival (a) and cancer-specific survival (b) between the pT0 and non-pT0 groupsBack to article page